West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
Appetite for Insurance M&A Remains as AI Enters the Chat, Says PwC 
Claimants of 23andMe Data Breach to Get $46.75M in Settlement Deal 
California Homeowners Insurance Costs Still 41% Below National Average, Report Shows 
Older, Wealthier Renters Drive Changes in Insurance Needs 
